LHON Gene Therapy GS010 Study Data to be Presented at NANOS Meeting – Mitochondrial Disease News
|
LHON Gene Therapy GS010 Study Data to be Presented at NANOS Meeting
Mitochondrial Disease News GenSight Biologics will present data from studies of its gene therapy GS010 for Leber hereditary optic neuropathy (LHON), a mitochondrial disease, at an upcoming Neuro-Ophthalmology Society conference. According to a press release, the one oral and two … |
